Miguel Ezcurra
About Miguel Ezcurra
Miguel Ezcurra is a Principal in Investment Risk at Apollo Global Management Inc., with a robust background in finance and risk management. He has held various roles in prominent financial institutions and possesses expertise in asset-liability management and structured transactions.
Current Role at Apollo Global Management
Miguel Ezcurra serves as Principal in Investment Risk at Apollo Global Management Inc. since 2017. In this role, he focuses on managing investment risks and developing strategies to mitigate potential financial exposures. His responsibilities include analyzing market trends and assessing the risk associated with various investment portfolios. His tenure at Apollo has allowed him to leverage his extensive background in risk management to contribute to the firm's investment strategies.
Previous Experience at Swiss Re
Before joining Apollo, Miguel worked at Swiss Re as Senior Market Risk Manager - Cro from 2011 to 2017. During his six years in Zurich, he was responsible for overseeing market risk management activities. His role involved evaluating risk exposures and implementing strategies to manage potential financial impacts. This experience enhanced his expertise in asset-liability management and structured transactions.
Educational Background in Finance and Economics
Miguel Ezcurra has a strong educational foundation in finance and economics. He earned a Doctorate in Financial Economics from Universidad De Santiago De Compostela between 2008 and 2012. Prior to that, he completed a Master's in Finance at Universidad Nacional De Educación a Distancia from 2004 to 2007 and a Master of Science at Universidad Carlos III de Madrid in 2000-2001. Additionally, he studied Economics and Business Administration at Universidad Complutense de Madrid from 1995 to 2000.
Expertise in Risk Management and Structured Finance
Miguel possesses significant expertise in market and credit risk management, with a focus on structured transactions involving corporate finance and insurance hybrid risks. He has extensive experience in structuring and originating securitized products and structured life and health deals. His knowledge extends to asset-liability management activities and the restructuring and investing in distressed debt assets.
Advisory Role at Zeclinics
In addition to his role at Apollo, Miguel has been serving as a Financial Advisor at Zeclinics since 2016. Zeclinics specializes in drug discovery through zebrafish technology. In this capacity, he provides financial guidance and strategic advice, drawing on his extensive experience in finance and investment risk management.